Senseonics Holdings, Inc. (SENS)
| Market Cap | 808.76M |
| Revenue (ttm) | 4.95M |
| Net Income (ttm) | -175.17M |
| Shares Out | 227.91M |
| EPS (ttm) | -0.77 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Dividend Yield | n/a |
| Trading Day | April 16 |
| Last Price | $1.89 |
| Previous Close | $1.98 |
| Change ($) | -0.09 |
| Change (%) | -4.55% |
| Day's Open | 1.88 |
| Day's Range | 1.78 - 2.03 |
| Day's Volume | 23,168,227 |
| 52-Week Range | 0.35 - 5.56 |
Senseonics will likely rise on the same trajectory as DexCom. SENS stock could rise 5 to 10 times over the next five years once it receives FDA approval.
SENS stock is banking on an FDA approval for its diabetes sensor. However, you'll want to analyze the fundamentals before proceeding.
GERMANTOWN, Md.--(BUSINESS WIRE)--Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and commercialization of a long-term, implantable continuous gl...
Investors need to pay close attention to Senseonics (SENS) stock based on the movements in the options market lately.
Is SENS stock really just another "meme stock"? After examining Senseonics' tech innovations, it's clear that this is a serious investment.
Senseonics (SENS) delivered earnings and revenue surprises of -9.09% and 12.72%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?
GERMANTOWN, Md.--(BUSINESS WIRE)--Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and commercialization of long-term, implantable continuous gluc...
GERMANTOWN, Md.--(BUSINESS WIRE)--Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and commercialization of long-term, implantable continuous gluc...
GERMANTOWN, Md.--(BUSINESS WIRE)--Senseonics Holdings, Inc. (NYSE-American: SENS), a medical technology company focused on the development and commercialization of long-term, implantable continuous gluc...
Investors need to pay close attention to Senseonics (SENS) stock based on the movements in the options market lately.
GERMANTOWN, Md,--(BUSINESS WIRE)--Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and commercialization of long-term, implantable continuous gluc...
GERMANTOWN, Md.--(BUSINESS WIRE)--Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and commercialization of long-term, implantable continuous gluc...
The movement of retail traders against hedge funds has caused several stocks to spike. Many of the top movers have been stocks that have a high percentage of their floated shares short, causing what's k...
GERMANTOWN, Md.--(BUSINESS WIRE)--Senseonics Holdings, Inc. (NYSE American: SENS) (“Senseonics” or the “Company”), a medical technology company focused on the development and commercialization of a long...
Senseonics Holdings (SENS) has moved higher as of late, but there could definitely be trouble on the horizon for this company.
GERMANTOWN, Md.--(BUSINESS WIRE)--Senseonics Holdings, Inc. (NYSE American: SENS) (“Senseonics” or the “Company”), a medical technology company focused on the development and commercialization of a long...
GERMANTOWN, Md.--(BUSINESS WIRE)--Senseonics Holdings, Inc. (NYSE American: SENS) (“Senseonics” or the “Company”), a medical technology company focused on the development and commercialization of a long...
Senseonics Holdings, Inc (AMEX: SENS) shares spiked nearly 87% in the regular and after-hour sessions on Tuesday. What Happened: The medical technology company said EmblemHealth, one of the largest not-...
The specialist in glucose monitoring is helping people with diabetes manage their health.
GERMANTOWN, Md.--(BUSINESS WIRE)--Senseonics Holdings, Inc. (NYSE American: SENS) a medical technology company focused on the development and commercialization of long-term, implantable continuous gluco...
GERMANTOWN, Md.--(BUSINESS WIRE)--Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and commercialization of long-term, implantable continuous gluc...
Senseonics Holdings (SENS) stock is on the rise Friday with heavy trading despite a lack of news concerning the pharmaceutical company. The post SENS Stock Alert: 10 Things to Know Before Investing in S...
Investors need to pay close attention to Senseonics Holdings (SENS) stock based on the movements in the options market lately.
GERMANTOWN, Md.--(BUSINESS WIRE)--Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and commercialization of a long-term, implantable continuous gl...
GERMANTOWN, Md.--(BUSINESS WIRE)--Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and commercialization of long-term, implantable continuous gluc...
This article is going to explain what penny stocks are and discuss four penny stocks under $1 to watch as small-cap stocks continue a hot streak this winter. First thing's first, what are penny stocks?
Investors need to pay close attention to Senseonics (SENS) stock based on the movements in the options market lately.
Senseonics Holdings (SENS) saw a big move last session, as its shares jumped more than 5% on the day, amid huge volumes.
Senseonics has had a large win via the Ascensia Diabetes collaboration structure, that creates shareholder value with long-tailed returns. The Eversense device will benefit from Ascensia's large footpri...
Senseonics Holdings, Inc. (SENS) CEO Tim Goodnow on Q3 2020 Results - Earnings Call Transcript
Senseonics (SENS) delivered earnings and revenue surprises of -66.67% and -2.42%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?
GERMANTOWN, Md.--(BUSINESS WIRE)--Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and commercialization of long-term, implantable continuous gluc...
GERMANTOWN, Md.--(BUSINESS WIRE)--Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and commercialization of long-term, implantable continuous gluc...
GERMANTOWN, Md.--(BUSINESS WIRE)--Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and commercialization of long-term, implantable continuous gluc...
Senseonics (SENS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
GERMANTOWN, Md.--(BUSINESS WIRE)--Senseonics Holdings, Inc. (NYSE-American: SENS), a medical technology company focused on the development and commercialization of long-term, implantable continuous gluc...
GERMANTOWN, Md.--(BUSINESS WIRE)--Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and commercialization of a long-term, implantable continuous gl...
GERMANTOWN, Md.--(BUSINESS WIRE)--Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and commercialization of long-term, implantable continuous gluc...
GERMANTOWN, Md.--(BUSINESS WIRE)--Senseonics Holdings, Inc.
Investors need to pay close attention to Senseonics (SENS) stock based on the movements in the options market lately.
Senseonics Holdings, Inc. (SENS) CEO Tim Goodnow on Q2 2020 Results - Earnings Call Transcript
Senseonics (SENS) delivered earnings and revenue surprises of 100.00% and -76.27%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?
GERMANTOWN, Md.--(BUSINESS WIRE)--Senseonics Holdings, Inc.
GERMANTOWN, Md.--(BUSINESS WIRE)--Senseonics Holdings, Inc.
TOKYO and BASEL, Switzerland, Aug. 10, 2020 /PRNewswire/ -- PHC Holdings Corporation and Ascensia Diabetes Care, a PHC Group company, today announced a strategic partnership with Senseonics Holdings, Inc.
GERMANTOWN, Md.--(BUSINESS WIRE)--Senseonics Holdings, Inc.
GERMANTOWN, Md.--(BUSINESS WIRE)--Senseonics Holdings, Inc.
NEW YORK, Aug. 3, 2020 /PRNewswire/ -- Purcell Julie & Lefkowitz LLP, a class action law firm dedicated to representing shareholders nationwide, is investigating a potential breach of fiduciary duty cla...
Senseonics (SENS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Senseonics Holdings (SENS) saw a big move last session, as its shares jumped nearly 6% on the day, amid huge volumes.
About SENS
Senseonics Holdings, Inc., a medical technology company, develops and commercializes continuous glucose monitoring (CGM) systems for people with diabetes in the United States, Europe, the Middle East, and Africa. The company's products include Eversense and Eversense XL, which are implantable CGM systems to measure glucose levels in people with diabetes through an under-the-skin sensor, a removable and rechargeable smart transmitter, and a convenient app for real-time diabetes monitoring and management for a period of up to 90 and 180 days. It ... [Read more...]
| Industry Diagnostics & Research | Founded 1996 |
| CEO Timothy Goodnow | Employees 82 |
| Stock Exchange NYSEAMERICAN | Ticker Symbol SENS |
Financial Performance
In 2020, SENS's revenue was $4.95 million, a decrease of -76.77% compared to the previous year's $21.30 million. Losses were -$175.17 million, 51.6% more than in 2019.
Analyst Forecasts
According to 7 analysts, the average rating for SENS stock is "Buy." The 12-month stock price forecast is 2.55, which is an increase of 34.92% from the latest price.